Mechanisms Underlying Selective Vulnerability in Subcortical Aminergic Nuclei in Alzheimer's Disease

Alexander J. Ehrenberg
Doctoral Candidate in Integrative Biology
Helen Wills Neuroscience Institute, University of California, Berkeley

Learning Objectives

• Identify cell signaling pathways that create a substrate for neurodegenerative disease vulnerability.
• Understand the limitations and value created by molecular neuropathological approaches for probing neurodegenerative disease vulnerability.
• Describe experimental approaches to test mechanistic hypotheses for selective vulnerability and identify therapeutic targets.

Disclosures

• Planners: Bruce L. Miller, MD; Howard J. Rosen, MD; Anil Vora; and Janet Allen-Williams have stated they have no relationships to disclose.
• Speaker: Alexander Ehrenberg has stated he has no relationships to disclose.

Accreditation: The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation: UCSF designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit is inclusive of all Memory and Aging Center Grand Rounds sessions offered from January 1, 2024, through December 31, 2024. (1 credit per each 1-hour grand rounds session throughout the year).

Questions? Email MAC Executive Analyst, Anil Vora.

Attendees must register for this event. Grand Rounds presentations are for educational purposes and intended for a professional audience with a terminal degree. This activity is not commercially supported.